Literature DB >> 16275219

In vitro fertilization is associated with an increase in major birth defects.

Christine K Olson1, Kim M Keppler-Noreuil, Paul A Romitti, William T Budelier, Ginny Ryan, Amy E T Sparks, Bradley J Van Voorhis.   

Abstract

OBJECTIVE: To determine the risk of major birth defects in cohorts of children conceived through IVF or through IUI as compared with naturally conceived children.
DESIGN: Retrospective cohort study.
SETTING: Academic medical center. PATIENT(S): Children conceived by IVF or IUI at the University of Iowa from 1989 through 2002, compared with a matched cohort of naturally conceived children. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Outcome data were obtained from Iowa state birth and fetal death certificates and from the Iowa Birth Defects Registry. RESULT(S): Ninety of 1,462 IVF-conceived children (6.2%) and 17 of 343 IUI-conceived children (5.0%) had a major birth defect, compared with 369 of 8,422 naturally conceived children (4.4%). The adjusted odds ratio of a major birth defect in all IVF-conceived children was 1.30 (95% confidence interval [CI] 1.00-1.67) and 1.11 (95% CI 0.67-1.84) for IUI-conceived children. The birth defect rate was increased after IVF when the analysis was limited to term singletons. Cardiovascular and musculoskeletal defects and known birth defect syndromes were increased after IVF. Among IVF-conceived children, there was no difference in birth defect rates after intracytoplasmic sperm injection (ICSI) or after transfer of cryopreserved embryos. CONCLUSION(S): Infants conceived through IVF have a slightly higher rate of major birth defects. More birth defects are noted among children born to infertile couples treated with IUI, although this difference is not statistically significant. Larger studies of infants conceived by infertile couples after all types of infertility treatment are needed to definitively determine whether the increased risk of birth defects is secondary to problems inherent in the infertile couple and/or factors associated with some aspect of the treatment.

Entities:  

Mesh:

Year:  2005        PMID: 16275219     DOI: 10.1016/j.fertnstert.2005.03.086

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  44 in total

1.  The Pregnancy in Polycystic Ovary Syndrome II (PPCOS II) trial: rationale and design of a double-blind randomized trial of clomiphene citrate and letrozole for the treatment of infertility in women with polycystic ovary syndrome.

Authors:  Richard S Legro; Allen R Kunselman; Robert G Brzyski; Peter R Casson; Michael P Diamond; William D Schlaff; Gregory M Christman; Christos Coutifaris; Hugh S Taylor; Esther Eisenberg; Nanette Santoro; Heping Zhang
Journal:  Contemp Clin Trials       Date:  2012-01-13       Impact factor: 2.226

Review 2.  Intracytoplasmic sperm injection (ICSI)--what are the risks?

Authors:  Joseph P Alukal; Dolores J Lamb
Journal:  Urol Clin North Am       Date:  2008-05       Impact factor: 2.241

3.  ART, birth defects and subfertility--what should prospective patients be told?

Authors:  Michele Hansen; Elizabeth Milne; Nicholas de Klerk; Jennifer J Kurinczuk; Peter Jacoby; Carol Bower
Journal:  J Assist Reprod Genet       Date:  2011-09-01       Impact factor: 3.412

4.  No difference in congenital anomalies prevalence irrespective of insemination methods and freezing procedure: cohort study over fourteen years of an ART population in the south of France.

Authors:  Any Beltran Anzola; Vanessa Pauly; Debbie Montjean; Line Meddeb; Cendrine Geoffroy-Siraudin; Roland Sambuc; Pierre Boyer; Marie-José Gervoise-Boyer
Journal:  J Assist Reprod Genet       Date:  2017-03-23       Impact factor: 3.412

5.  The risk for four specific congenital heart defects associated with assisted reproductive techniques: a population-based evaluation.

Authors:  Karim Tararbit; Nathalie Lelong; Anne-Claire Thieulin; Lucile Houyel; Damien Bonnet; François Goffinet; Babak Khoshnood
Journal:  Hum Reprod       Date:  2012-11-22       Impact factor: 6.918

6.  Birth defects after assisted reproductive technology according to the method of treatment in Japan: nationwide data between 2004 and 2012.

Authors:  Syuichi Ooki
Journal:  Environ Health Prev Med       Date:  2015-08-22       Impact factor: 3.674

7.  How Humanae vitae has advanced reproductive health.

Authors:  Derek M Doroski
Journal:  Linacre Q       Date:  2014-08

8.  Effect of sperm entry on blastocyst development after in vitro fertilization and intracytoplasmic sperm injection - mouse model.

Authors:  Karolina Piotrowska-Nitsche; Anthony W S Chan
Journal:  J Assist Reprod Genet       Date:  2012-12-08       Impact factor: 3.412

Review 9.  Sperm DNA damage in male infertility: etiologies, assays, and outcomes.

Authors:  Ryan T Schulte; Dana A Ohl; Mark Sigman; Gary D Smith
Journal:  J Assist Reprod Genet       Date:  2009-12-12       Impact factor: 3.412

10.  In vitro fertilization and embryo culture strongly impact the placental transcriptome in the mouse model.

Authors:  Patricia Fauque; Françoise Mondon; Franck Letourneur; Marie-Anne Ripoche; Laurent Journot; Sandrine Barbaux; Luisa Dandolo; Catherine Patrat; Jean-Philippe Wolf; Pierre Jouannet; Hélène Jammes; Daniel Vaiman
Journal:  PLoS One       Date:  2010-02-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.